The New York Stock Exchange remained the leading exchange globally for capital raising in the first half of 2015, with 264 transactions raising a total of $94 billion. This includes 42 companies that raised $12 billion from initial public offerings (IPOs) in the first half of 2015.
With leadership across multiple sectors, NYSE led with 100% of REIT IPOs and 70% of all private equity-backed IPO proceeds, while gaining momentum in healthcare, including one of the largest biotech IPOs ever in Axovant Sciences (NYSE: AXON.) Consistent with its leadership in technology IPOs since 2012, the NYSE welcomed 10 technology IPOs raising $2.6 billion, which represents 66% of all capital raised from U.S. tech IPOs. Additionally, more than 85% of exchange traded products (ETPs) listed on NYSE Arca during the first half of the year.
“Nothing has the power to unlock capital to drive innovation, create new jobs and enable long-term growth like an IPO,” said Garvis Toler, NYSE Head of Global Capital Markets. “We take our role in the capital formation process very seriously and are proud to support our issuer community, which includes global innovators across all sectors from technology and healthcare to financial services and energy. The momentum continues amid a healthy IPO landscape, and we continue to see a strong pipeline for offerings through the rest of the year.”